DGAP-PVR: RHÃ?N-KLINIKUM AG: Release according to Article

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Oct 17, 2013 at 3:00 AM

DGAP-PVR: RHÃ?N-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

RHÃ?N-KLINIKUM AG 17.10.2013 08:49 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification according to section 26 para. 1 WpHG B. Braun Holding GmbH & Co. KG, Melsungen, Germany, BraHo Verwaltungsgesellschaft mbH, Melsungen, Germany, Ludwig G. Braun GmbH & Co. KG, Melsungen, Germany, Prof. Dr. h.c. Ludwig Georg Braun, Germany, Martin LÃ¼dicke, Germany, and Ilona Braun, Germany, notified us pursuant to section 25 para. 1 WpHG of the following: 1) On 14 October 2013, B. Braun Holding GmbH & Co. KG exceeded the threshold of 5% and 10% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft arising from 15,172,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly (chain of controlled undertakings: B. Braun Melsungen Aktiengesellschaft; expiration date of the instruments pursuant to section 25 WpHG: 22 December 2014). 2) On 14 October 2013, BraHo Verwaltungsgesellschaft mbH exceeded the threshold of 5% and 10% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, BraHo Verwaltungsgesellschaft mbH held 10.98% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft arising from 15,172,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly (chain of controlled undertakings: B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft; expiration date of the instruments pursuant to section 25 WpHG: 22 December 2014). 3) On 14 October 2013, Ludwig G. Braun GmbH & Co. KG exceeded the threshold of 5% and 10% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Ludwig G. Braun GmbH & Co. KG held 10.98% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft arising from 15,172,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly (chain of controlled undertakings: B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft; expiration date of the instruments pursuant to section 25 WpHG: 22 December 2014). 4) On 14 October 2013, Prof. Dr. h.c. Ludwig Georg Braun exceeded the threshold of 5% and 10% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Prof. Dr. h.c. Ludwig Georg Braun held 10.98% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft arising from 15,172,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly (chain of controlled undertakings: Ludwig G. Braun GmbH & Co. KG, B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft; expiration date of the instruments pursuant to section 25 WpHG: 22 December 2014). 5) On 14 October 2013, Martin LÃ¼dicke exceeded the threshold of 5% and 10% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Martin LÃ¼dicke held 10.98% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft arising from 15,172,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly (chain of controlled undertakings: BraHo Verwaltungsgesellschaft mbH, B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft; expiration date of the instruments pursuant to section 25 WpHG: 22 December 2014). 6) On 14 October 2013, Ilona Braun exceeded the threshold of 5% and 10% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Ilona Braun held 10.98% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft arising from 15,172,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly (chain of controlled undertakings: BraHo Verwaltungsgesellschaft mbH, B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft; expiration date of the instruments pursuant to section 25 WpHG: 22 December 2014). Bad Neustadt a.d. Saale, 17 October 2013 The Board of Management ________________________________________________________________ Dr. Kai G. Klinger Head of Investor Relations RHÃ?N-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 17.10.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÃ?N-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...